Rua Life Sciences PLC
LSE:RUA

Watchlist Manager
Rua Life Sciences PLC Logo
Rua Life Sciences PLC
LSE:RUA
Watchlist
Price: 12.4 GBX -0.8% Market Closed
Market Cap: 7.7m GBX
Have any thoughts about
Rua Life Sciences PLC?
Write Note

Rua Life Sciences PLC
Depreciation & Amortization

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Rua Life Sciences PLC
Depreciation & Amortization Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Depreciation & Amortization CAGR 3Y CAGR 5Y CAGR 10Y
Rua Life Sciences PLC
LSE:RUA
Depreciation & Amortization
-ÂŁ364k
CAGR 3-Years
-10%
CAGR 5-Years
-11%
CAGR 10-Years
N/A
Abingdon Health PLC
LSE:ABDX
Depreciation & Amortization
-ÂŁ673k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
ConvaTec Group PLC
LSE:CTEC
Depreciation & Amortization
-$42.2m
CAGR 3-Years
-12%
CAGR 5-Years
-9%
CAGR 10-Years
N/A
Tristel PLC
LSE:TSTL
Depreciation & Amortization
-ÂŁ2.6m
CAGR 3-Years
-1%
CAGR 5-Years
-10%
CAGR 10-Years
-11%
Inspecs Group PLC
LSE:SPEC
Depreciation & Amortization
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Advanced Medical Solutions Group PLC
LSE:AMS
Depreciation & Amortization
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Rua Life Sciences PLC
Glance View

Market Cap
7.7m GBX
Industry
Health Care

RUA Life Sciences Plc is a holding company, which engages in the commercialization of biomedical polymer technology, components, and medical devices. The company is headquartered in Ayrshire, Ayrshire and currently employs 32 full-time employees. The firm is a manufacturer of medical devices and licensor of its IP and know-how together with developing medical devices utilizing its polymer IP. The firm operates through four businesses. Its RUA Medical business provides sub-contract manufacturing, assembly, packing and services to the medical device sector from its Class seven and eight cleanroom suites. Its RUA Biomaterials is the depository of the IP and licensing rights to a range of biostable, implantable polymers, including Elast-EonTM and ECSilTM. Its RUA Vascular business is the legal manufacturer and IP holder of the Company’s cardiovascular and soft tissue patches and bore vascular grafts. Its RUA Structural Heart business holds the intellectual property relating to the Company’s synthetic heart valve technology.

RUA Intrinsic Value
10.35 GBX
Overvaluation 17%
Intrinsic Value
Price

See Also

What is Rua Life Sciences PLC's Depreciation & Amortization?
Depreciation & Amortization
-364k GBP

Based on the financial report for Mar 31, 2024, Rua Life Sciences PLC's Depreciation & Amortization amounts to -364k GBP.

What is Rua Life Sciences PLC's Depreciation & Amortization growth rate?
Depreciation & Amortization CAGR 5Y
-11%

Over the last year, the Depreciation & Amortization growth was -2%. The average annual Depreciation & Amortization growth rates for Rua Life Sciences PLC have been -10% over the past three years , -11% over the past five years .

Back to Top